IMPACT OF AUTOIMMUNE DISEASES (E.G., SYSTEMIC LUPUS ERYTHEMATOSUS) ON PREGNANCY OUTCOMES
Keywords:
autoimmune disease, SLE, pregnancyAbstract
Autoimmune diseases, particularly Systemic Lupus Erythematosus (SLE), significantly affect pregnancy outcomes due to immune dysregulation, chronic inflammation, and multi-organ involvement. Women of reproductive age are disproportionately affected by autoimmune conditions, making pregnancy management a complex clinical challenge. SLE is associated with increased risks of preeclampsia, fetal growth restriction, preterm birth, and pregnancy loss. Additionally, the presence of antiphospholipid antibodies further increases thrombotic complications and adverse fetal outcomes. This article reviews the epidemiology, pathophysiology, clinical manifestations, and management of autoimmune diseases during pregnancy, emphasizing the importance of multidisciplinary care.
References
1. World Health Organization (2022). Autoimmune diseases and pregnancy report.
2. Lateef A, Petri M. (2012). SLE and pregnancy. Rheumatic Disease Clinics.
3. Clowse MEB. (2016). Lupus in pregnancy. BMJ.
4. Smyth A et al. (2010). Outcomes in lupus pregnancy. Lancet.
5. Andreoli L et al. (2017). APS guidelines. Annals of Rheumatic Diseases
6. Buyon JP et al. (2015). Neonatal lupus. Journal of Clinical Investigation
7. Lockshin MD. (2013). Pregnancy in lupus.
8. Ruiz-Irastorza G et al. (2010). Management of SLE.
9. Clark CA et al. (2016). APS and pregnancy
10. EULAR Recommendations (2017). SLE management
